I’m pleased to share a biography that reflects my journey as a global pharmaceutical and biotechnology executive across medical affairs, clinical development, regulatory strategy, and commercialization. Over the past three decades, I’ve had the opportunity to lead across respiratory, rare disease, oncology, endocrinology, infectious disease, and global market expansion while building teams, advancing innovation, and supporting product launches worldwide. Here is my biography.

Dr. Michael E. Kuligowski, MD, PhD, MBA, is a globally recognized physician-executive with over four decades of leadership in dermatology, clinical development, and pharmaceutical strategy. With a distinguished career spanning Europe and the United States, he has led the development and approval of numerous dermatologic therapies, including Opzelura® for atopic dermatitis and vitiligo. Known for his scientific rigor, strategic foresight, and collaborative leadership, Dr. Kuligowski continues to influence the future of dermatologic innovation through executive roles, advisory board appointments, and pro-bono consulting in the life sciences sector.